The forecast for scientific publications in pharmacy in China shows a steady increase from 2024 to 2028, with values rising from 35 in 2024 to 40.27 in 2028. The year-on-year growth from 2024 to 2025 is approximately 3.8%, indicating a consistent upward trend. The cumulative average growth rate (CAGR) for 2024 to 2028 is about 3.59%. The consistent rise suggests a growing emphasis on pharmaceutical research in China, building on the foundational work achieved up until 2023.
Future trends to watch for include potential acceleration in publication growth driven by increased research funding, international collaborations, and innovative technological advancements within China's pharmaceutical sector. Monitoring policy changes and educational capacity expansion in China will also be crucial to anticipating shifts in publication volumes.
